Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →
logo
Get CLEATUS

Candidate Vaccine Virus (CVV) Development & Characterization

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract, titled Candidate Vaccine Virus Development and Characterization, supports BARDA pandemic preparedness projects by preparing and characterizing both non-GLP and GLP influenza Candidate Vaccine Viruses. The scope of work includes performing HA/NA sequencing, genetic stability testing, ferret pathogenicity, two-way antigenicity, HA titer, sterility, and exclusivity. Additionally, the contractor is responsible for conducting plaque assays and chicken embryo lethality for HPAI strains within a BSL-2 environment, culminating in the delivery of final reports and Certificates of Analysis or Compliance. Managed by the Department of Health and Human Services under the Barda - Aspr agency, the project is categorized under NAICS code 541714. The performance location is based in Washington, DC. The solicitation was posted on August 17, 2026, with a response deadline set for October 30, 2026.

General Info

BARDA subcontract for developing and characterizing influenza candidate vaccine viruses in Washington, DC.

Agency

Department Of Health And Human Services → Barda - Aspr / Daappo / Barda DcmaView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

Washington, DC, 20024, USA

Set-Aside

NONE

Documents

This scope was carved out of 75A50126R00001_RFP_NPIVS_27.

The full solicitation package (19 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Prepares and characterizes non-GLP and GLP influenza Candidate Vaccine Viruses (CVVs) for prime contractors on BARDA pandemic preparedness projects. Performs HA/NA sequencing, genetic stability, ferret pathogenicity, 2-way antigenicity, HA titer, sterility, and exclusivity. Conducts chicken embryo lethality and plaque assays for HPAI strains in a BSL-2 environment. Delivers final reports and Certificates of Analysis/Compliance.

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Federal
study entitled “Malaria and vector borne disease surveillance in the Colombia/Venezuela border”
Solicitation # ERP_1301373256
The Naval Medical Research Unit South in Lima, Peru, is seeking a provider to conduct a study focused on malaria and vector borne disease surveillance along the Colombia and Venezuela border. While the government has identified the Administrators of Tulane Educational Fund as the only vendor currently capable of supporting the entire requirement, they are issuing this notice to identify other capable sources before proceeding with a sole source award under FAR 13.106-1(b)(i). Interested parties must submit a capability statement including technical, management, and cost data to Genaro Vasquez via email by 12:00 PM local time on September 18, 2026. Submissions must be in Microsoft Word or PDF format, not exceed five pages, and use the subject line ERP_1301373256. The government will use these submissions to determine whether to pursue a competitive procurement or move forward with the intended sole source contract.
Naval Medical Research Center

POSTED

about 12 hours ago

DEADLINE

in 9 days
View Details
NAICS: 541714
New
Federal
Cryo-Electron Microscopy (Cryo-EM) Services
Solicitation # 75N98026Q01177
The National Institutes of Health Olao, under the Department of Health and Human Services, is seeking providers for Cryo-Electron Microscopy (Cryo-EM) Services under solicitation number 75N98026Q01177. This combined contract opportunity is categorized under NAICS code 541714 and is managed by the office located in Bethesda, Maryland. Interested parties must submit their responses by the deadline of September 16, 2026, at 6:00 PM. The primary point of contact for this procurement is Roxane S. Burkett.
National Institutes Of Health Olao

POSTED

about 12 hours ago

DEADLINE

in 7 days
View Details
NAICS: 541714
New
Federal
AMPLICON SEQUENCING SERVICES
Solicitation # 140G0226Q0047
Ofc Of Acquisition Grants-Denver

POSTED

about 12 hours ago

DEADLINE

in 2 days
View Details
NAICS: 541714
New
Federal
TIDAL: Target-Induced Droplet Assembly of Ligands
Solicitation # S-197478
Developed by Los Alamos National Laboratory, TIDAL (Target-Induced Droplet Assembly of Ligands) is a programmable protein-only material that utilizes nanobodies fused with encapsulation peptides to create dynamic, liquid-like droplets through phase separation. This technology allows for the precise concentration of binders upon encountering a target ligand, enabling a versatile platform for resin-free protein purification, high-sensitivity diagnostics, and the creation of slow-release drug depots. It can also function intracellularly to sequester and neutralize harmful proteins associated with viral infections or cancer. The technology is currently at TRL 3 with a patent pending and is available for exclusive or non-exclusive licensing through the Department of Energy contractor, Triad. Key market applications span biopharmaceutical manufacturing, therapeutics, and biotechnology. Interested parties can contact Caleb Ledgerwood or Lindsay Augustyn via the provided licensing email to explore commercial partnerships for this innovation.
Triad - DOE Contractor

POSTED

1 day ago

DEADLINE

in 3 months
View Details
NAICS: 541714
New
Federal
Chemical, Biological, Radiological and Nuclear Advance Defense Enabling Network and Clinical Capability (CADENCC)
Solicitation # W911SR-26-9-CADENCC
The Department of the Army, through the Army Contracting Command Edgewood Contracting Division and the Joint Project Lead Enabling Technologies, is seeking preproposals for the Chemical, Biological, Radiological and Nuclear Advance Defense Enabling Network and Clinical Capability project. This initiative aims to accelerate clinical trial startups for CBRN defense readiness by implementing Master Protocols, utilizing innovative technologies for decentralized trial operations, and establishing a pre-positioned clinical trial site network. The project will primarily focus on Phase I and Phase II clinical trials for early treatment products, post-exposure prophylaxis, and pre-exposure prophylaxis, including those under the Animal Rule. This opportunity is issued under 10 USC 4022 Other Transaction Authority for a prototype project, with the potential for non-competitive follow-on production contracts for successful performers. Preproposals are due by 1500 hours on September 17, 2026, and must be limited to 10 pages. Evaluation will be based on technical merit, military relevance, technology readiness level 4 or above, regulatory compliance with FDA guidelines, and best overall value. Prospective awardees must be registered in the System for Award Management database.
W6QK Acc-Apg

POSTED

5 days ago

DEADLINE

in 8 days
View Details
NAICS: 541714
New
Federal
Future Program: Firefox
Solicitation # DARPA-SN-26-113
The Defense Advanced Research Projects Agency's Biological Technologies Office has issued Special Notice DARPA-SN-26-113 to announce research areas of interest for the upcoming Firefox program. This notice serves as a public notification for potential applicants regarding the agency's objectives and the contemplated forthcoming solicitation. The notice was posted on September 4, 2026, with a response deadline of September 11, 2026. Managed by the Department of Defense in Arlington, Virginia, the program falls under NAICS code 541714. Interested parties can contact Dr. Pedro Irazoqui for further information, and the official solicitation will be hosted on the SAM.gov website.
Defense Advanced Research Projects Agcy

POSTED

5 days ago

DEADLINE

in 1 day
View Details
NAICS: 541714
New
Federal
Rapid Prototyping and Hardware EngineerThis subcontract with the Defense Advanced Research Projects Agency focuses on the design, development, and manufacturing of next-generation military hardware for prime contractors. The scope of work involves executing rapid prototyping and scalable deployment strategies through the use of additive manufacturing and high-fidelity testing environments. Key deliverables include hardware prototypes, technical design documents, and comprehensive manufacturing scalability plans. The project requires strict adherence to NIST SP 800-171 and DoDI 8582.01 standards to ensure the protection of Controlled Unclassified Information. Classified under NAICS code 541714, the opportunity was posted on September 3, 2026, with a response deadline of June 1, 2027.
Defense Advanced Research Projects Agcy

POSTED

6 days ago

DEADLINE

in 9 months
View Details
NAICS: 541714
New
Federal
Q301--Strand-Specific RNA-Sequencing Services
Solicitation # 36C24126Q0788
Solicitation 36C24126Q0788 is a firm-fixed-price request for quotations issued by the Department of Veterans Affairs, Network Contracting Office 1, for strand-specific RNA-sequencing services to support the VA Bedford Healthcare System. This requirement is set aside 100 percent for small business concerns under NAICS 541714. The project involves the sequencing of 269 government-furnished human choroid plexus total RNA samples to support research on neurodegenerative diseases, including Alzheimer’s Disease and Chronic Traumatic Encephalopathy. The selected contractor must provide sample quality-control assessment, rRNA depletion-based library preparation, and Illumina paired-end 2x150bp sequencing at a depth of approximately 60 million read pairs per sample. The period of performance is one year from the date of award, with a strict turnaround requirement to complete all services and deliver FASTQ files and quality-control reports within 23 to 28 business days after receiving the samples as a single batch. Technical acceptance requires that at least 85 percent of bases achieve a Phred quality score of Q30 or greater. Data delivery is primarily via physical hard drive, though secure electronic delivery may be authorized. Award will be made to the responsible quoter submitting the lowest-priced technically acceptable quotation, based on an evaluation of the technical capability statement and total price. Quotations are due by September 10, 2026, at 11:00 AM Eastern Time.
241-NETWORK Contract Office 01 (36C241)

POSTED

6 days ago

DEADLINE

in about 15 hours
View Details
NAICS: 541714
New
Federal
Myocardial Intramural Remodeling by Transvenous tether (MIRTH) Implant Design Support and Feasibility Prototypes
Solicitation # 75N98026Q01129
The National Institutes of Health Nhlbi, under the Department of Health and Human Services, is seeking a contractor for the Myocardial Intramural Remodeling by Transvenous tether (MIRTH) Implant Design Support and Feasibility Prototypes project. This presolicitation, identified by solicitation number 75N98026Q01129, falls under NAICS code 541714 and focuses on the design and prototyping of medical implants. The project will be performed in Bethesda, Maryland. Interested parties must submit their responses by the deadline of September 10, 2026, at 4:00 PM. Primary inquiries and coordination for this effort are managed by Noelle Decenzo.
National Institutes Of Health Nhlbi

POSTED

6 days ago

DEADLINE

in about 16 hours
View Details
NAICS: 541714
New
Federal
Hypobaric Chamber Pilot Studies
Solicitation # 80JSC026Q0006
NASA Johnson Space Center is soliciting quotes under RFQ 80JSC026Q0006 for pilot hypobaric chamber testing facilities to support decompression sickness research for the Artemis program. The primary objective is to validate non-NASA resources for safe prebreathe procedures and extravehicular activity. The contractor must provide all personnel, equipment, and facilities to conduct three test days, recruiting at least two subjects per day to demonstrate the ability to meet NASA testing throughput and schedules. The base period of performance is from September 1, 2026, to September 30, 2027, with several optional work items available through September 30, 2029, including additional test days, pharmaceutical-enhanced prebreathe, and body temperature studies. This is a small business set-aside acquisition under NAICS 541714. Awards will be made based on a trade-off analysis where technical acceptability and past performance are significantly more important than price. Technical evaluation focuses on facility capabilities, medical support, team expertise, and the proposed schedule. Offerors must submit their quotes by September 10, 2026, at 1:00 p.m. Central Time. Submissions must include a completed pricing sheet and documentation of qualifications as specified in the additional submission criteria. The contract is governed by FAR Part 12 for commercial products and services and includes a total duration not to exceed five years.
NASA Johnson Space Center

POSTED

6 days ago

DEADLINE

in about 19 hours
View Details
NAICS: 541714
New
Federal
HUBBLE Proposers Day
Solicitation # DARPA-SN-26-121
The Defense Advanced Research Projects Agency's Biological Technologies Office is hosting a Proposers Day for the High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators program. This event is scheduled for September 25, 2026, from 12:00 PM to 5:00 PM Eastern Time at the SPA Arlington Research Collaboration Center in Arlington, Virginia. While a hybrid option is available for attendees, all presenters are required to be present in person. Interested parties must complete advance registration by the response deadline of September 18, 2026. This special notice, identified by solicitation number DARPA-SN-26-121 and NAICS code 541714, serves as a preparatory step for a planned Program Announcement. Primary coordination for the event is managed by Dr. Abhishek Singharoy.
Defense Advanced Research Projects Agcy

POSTED

6 days ago

DEADLINE

in 9 days
View Details
NAICS: 541714
Federal
JELA - 15780 - SAV-SP env & ecol monitoring - phase 2 - Task AgreementThe Department of the Interior is seeking services for Phase 2 environmental and ecological monitoring under the SAV-SP Task Agreement. This project involves the collection and analysis of monitoring data to evaluate ecological conditions, culminating in a synthesized report that provides critical findings and recommendations to inform resource management decisions. Classified under NAICS code 541714, this opportunity is currently listed as a forecast with a posted date of September 2, 2026. Interested parties may contact Rebecca Lasell or the Contract Support Center for further information regarding this effort.

POSTED

7 days ago

DEADLINE

N/A
View Details

More opportunities from Department Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma

Same awarding agency

NAICS: 325412
Federal
Vaccine Lot Production (Research, Investigational, and Commercial)This subcontract involves the production of influenza vaccine antigens and vaccines across research, investigational, and commercial bulk scales to support prime contractors on BARDA pandemic preparedness projects. The work is performed within cGMP compliant facilities to ensure all investigational and commercial lots meet strict regulatory alignment and quality standards. Managed by the Department of Health and Human Services under the Barda agency, the contract focuses on delivering bulk vaccine lots across three distinct production scales. The opportunity is categorized under NAICS code 325412, with a response deadline set for October 30, 2026, and performance based in Washington.
Pharmaceutical Preparation Manufacturing

POSTED

23 days ago

DEADLINE

in about 2 months
View Details
NAICS: 325412
Federal
cGMP Vaccine Seed Lot ManufacturingThis subcontract for cGMP Vaccine Seed Lot Manufacturing involves the production of yield-optimized Master Virus Seed, Working Virus Seed lots, or bacterial cell banks to support BARDA pandemic preparedness projects. The work is performed for prime contractors using qualified CVV reference strains within cGMP certified facilities that align with FDA-licensed vaccines or submitted BLAs. All seeds are characterized according to qualified internal standard operating procedures to ensure the delivery of certified lots. Managed by the Department of Health and Human Services under Barda, the contract falls under NAICS code 325412. The performance location is based in Washington, DC, with a response deadline of October 30, 2026.
Pharmaceutical Preparation Manufacturing

POSTED

23 days ago

DEADLINE

in about 2 months
View Details
NAICS: 326199
Federal
Specialized Material Supply (Vials, Stoppers, Seals)This subcontract for Specialized Material Supply focuses on providing critical medical-grade components, including vials, stoppers, seals, and crimps, to support prime contractors on BARDA pandemic preparedness projects. The scope of work requires the delivery of physical inventory and the provision of comprehensive supply chain narratives that detail the country of origin and tariff exposure for all containment and closure materials. Managed by the Department of Health and Human Services under the agency Barda - Aspr / Daappo / Barda Dcma, the contract is categorized under NAICS code 326199. The place of performance is located in Washington, DC, with a response deadline set for October 30, 2026.
All Other Plastics Product Manufacturing

POSTED

23 days ago

DEADLINE

in about 2 months
View Details
NAICS: 493110
Federal
Labeling, Packaging, and Cold Chain StorageThis subcontract, managed by the Department of Health and Human Services under BARDA, focuses on providing essential labeling, packaging, and specialized stability storage for bulk and final vaccine products. The scope of work involves supporting prime contractors on pandemic preparedness projects by managing cold chain logistics and stability monitoring for commercial scale bulk antigens, final containers, and bulk adjuvants. The contractor is responsible for the delivery of packaged products and the provision of detailed stability reports. This opportunity is categorized under NAICS code 493110 and is based in Washington, DC. The response deadline for this requirement is October 30, 2026.
General Warehousing and Storage

POSTED

23 days ago

DEADLINE

in about 2 months
View Details
NAICS: 325412
Federal
Formulation, Filling, and Finishing ServicesThis subcontract for Formulation, Filling, and Finishing Services supports BARDA pandemic preparedness projects by providing final formulation and filling of antigens, adjuvants, or co-formulated products into final containers. The work is performed under cGMP compliant processes within sterile filling environments to ensure the delivery of high-quality filled vials and containers for prime contractors. The opportunity is managed by the Department of Health and Human Services under the Barda - Aspr / Daappo / Barda Dcma agency and is categorized under NAICS code 325412. The project is based in Washington, DC, with a response deadline of October 30, 2026.
Pharmaceutical Preparation Manufacturing

POSTED

23 days ago

DEADLINE

in about 2 months
View Details
NAICS: 325412
Federal
cGMP Adjuvant ManufacturingThis subcontract, titled cGMP Adjuvant Manufacturing, involves the production of clinical or commercial scale bulk lots of vaccine adjuvants to support BARDA pandemic preparedness projects. The primary objective is to manufacture these adjuvants within cGMP certified facilities to enhance the efficacy of influenza vaccines as part of United States Government efforts. The contract is managed by the Department of Health and Human Services under the agency Barda - Aspr / Daappo / Barda Dcma, with the place of performance located in Washington. The solicitation was posted on August 17, 2026, with a response deadline of October 30, 2026, and falls under NAICS code 325412.
Pharmaceutical Preparation Manufacturing

POSTED

23 days ago

DEADLINE

in about 2 months
View Details
NAICS: 541714
Federal
Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
Solicitation # 75A50126R00001_RFP_NPIVS_27
BARDA is seeking contractors to support the Vaccine Medical Countermeasures for Pandemic Influenza Preparedness and Response Program. The selected providers will be responsible for furnishing all necessary personnel, materials, and facilities to produce vaccines, antigens, and adjuvants for pandemic preparedness and public health emergencies. This includes generating and submitting critical analytical, clinical, and manufacturing data to the FDA to ensure rapid regulatory decisions and manufacturing readiness. To be eligible for this award, offerors must have experience producing vaccines against influenza and strains with pandemic potential. Mandatory qualifications include either holding a U.S. influenza vaccine license or demonstrating the development of an influenza vaccine through the submission of a Biologics License Application for seasonal or pandemic vaccines. This solicitation is managed by the Department of Health and Human Services with a response deadline of October 30, 2026.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

23 days ago

DEADLINE

in about 2 months
View Details
NAICS: 541715
Federal
Animal Model Development for Phosphine & Cyanide ExposureThis contract involves the development and validation of animal models designed to accurately replicate human exposure to phosphine and cyanide. These models are intended to be used for testing medical countermeasures under the FDA Animal Rule, which provides regulatory pathways for drugs and biologics when human trials are not ethical or feasible. The work falls under the subcontract category and is associated with the Department of Health and Human Services, specifically managed by BARDA (Biomedical Advanced Research and Development Authority) and affiliated offices. The focus of the effort is to create reliable and scientifically robust animal models that can simulate the toxicological and pharmacological effects of phosphine and cyanide exposure in humans. This will facilitate the evaluation and approval of medical treatments aimed at counteracting these toxic agents in emergency or threat scenarios. The contract aligns with NAICS code 541715, which involves research and development in the physical, engineering, and life sciences sectors. The solicitation was posted in April 2026, and although specific details on location and points of contact are not provided, the contract is accessible through official government procurement platforms.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

5 months ago

DEADLINE

N/A
View Details
NAICS: 541620
Federal
Expanded Biological Sample Analysis (Toxicology & Biomarkers)The contract involves the comprehensive analysis of biological samples, including blood, serum, and urine, to identify toxicological markers, conduct metabolomic profiling, and gather pharmacokinetic data. This work is aimed at assessing the safety and efficacy of medical countermeasures (MCM), supporting efforts to ensure that these interventions meet required safety standards and perform effectively in relevant scenarios. The contract falls under the NAICS code 541620, which relates to environmental consulting services, indicating specialized scientific and analytical work. Awarded by the Department of Health and Human Services through the Biomedical Advanced Research and Development Authority (BARDA), the subcontract focuses on advanced biological sample analysis as part of ongoing health protection initiatives. Although specific solicitation and contact details are not provided, the contract was posted in April 2026 and is intended to bolster toxicological and biomarker research critical to public health preparedness and response efforts. The work is conducted under the oversight of BARDA programs, underscoring its strategic importance in developing therapeutic and diagnostic solutions.
Environmental Consulting Services

POSTED

5 months ago

DEADLINE

N/A
View Details
NAICS: 541380
Federal
In Vivo Imaging and Data Acquisition (Preclinical)This contract involves conducting in vivo preclinical imaging using modalities such as MRI, CT, and PET to study live animal models during nonclinical investigations. The goal is to evaluate physiological responses to various chemical agents and medical countermeasures, supporting the assessment and development of these substances. The contract is issued as a subcontract under the NAICS code 541380 and is managed by the Department of Health and Human Services through its bureaus including BARDA and ASPR. The contract emphasizes data acquisition and analysis in preclinical settings, playing a critical role in advancing medical research and product development aimed at improving public health preparedness and response. The location details and point of contact information were not specified, but the contract was posted on April 22, 2026, reflecting ongoing efforts to support nonclinical study capabilities in biomedical research.
Testing Laboratories and Services

POSTED

5 months ago

DEADLINE

N/A
View Details
NAICS: 541611
Federal
Tissue Collection, Processing, and HistopathologyThis contract involves the collection, preservation, sectioning, and histological analysis of animal tissues following exposure to chemical agents and medical countermeasures (MCMs). The purpose is to support toxicology and efficacy assessments, ensuring thorough examination of tissue responses to these substances. The scope includes detailed processing and microscopic evaluation to provide critical data for understanding the biological effects and safety profiles of the tested agents. Issued by the Department of Health and Human Services under the BARDA-ASPR/DAAPO/BARDA DCMA umbrella, this subcontract falls under the NAICS code 541611, indicating professional, scientific, and technical services. The contract was posted on April 22, 2026, and although specific location details and points of contact are not provided, it is structured to facilitate specialized laboratory analysis essential for public health preparedness and response initiatives.
Administrative Management and General Management Consulting Services

POSTED

5 months ago

DEADLINE

N/A
View Details
NAICS: 541714
Federal
Nonclinical Animal Dose Escalation Studies (Schedule 1 Chemicals)This contract involves the execution of nonclinical dose escalation studies using highly hazardous chemical agents, such as phosphine and cyanide, in animal models. The primary goal is to evaluate the efficacy of medical countermeasures under the FDA’s Animal Rule, which allows for drug approval based on animal testing when human trials are not ethical or feasible. The work focuses on Schedule 1 chemicals, requiring strict adherence to safety and regulatory standards due to the high-risk nature of the substances involved. The contract is a subcontract under the Department of Health and Human Services, specifically managed by the Biomedical Advanced Research and Development Authority (BARDA) along with associated offices. It falls under the NAICS code 541714, which covers research and development in biotechnology. While specific details about the location of performance and points of contact are not provided, the contract supports the development of critical medical countermeasures aimed at protecting public health from chemical threats.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

5 months ago

DEADLINE

N/A
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS